How much profit has Abbott Laboratories made this year?
Abbott Laboratories has made 8.05 B USD this year.
In 2024, Abbott Laboratories's profit amounted to 8.05 B USD, a 40.71% increase from the 5.72 B USD profit recorded in the previous year.
YEAR | NET INCOME (undefined USD) |
---|---|
2028e | 12.81 |
2027e | 10.59 |
2026e | 9.94 |
2025e | 8.93 |
2024e | 8.05 |
2023 | 5.72 |
2022 | 6.93 |
2021 | 7.07 |
2020 | 4.5 |
2019 | 3.69 |
2018 | 2.37 |
2017 | 0.48 |
2016 | 1.4 |
2015 | 4.42 |
2014 | 2.28 |
2013 | 2.58 |
2012 | 5.96 |
2011 | 4.73 |
2010 | 4.63 |
2009 | 5.75 |
2008 | 4.88 |
2007 | 3.61 |
2006 | 1.72 |
2005 | 3.37 |
2004 | 3.24 |
The profit margins of Abbott Laboratories represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Abbott Laboratories's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Evaluating Abbott Laboratories's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Abbott Laboratories's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
When Abbott Laboratories’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Abbott Laboratories has made 8.05 B USD this year.
The profit has increased by 40.71% compared to last year increased
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
Abbott Laboratories publishes its earnings in the form of quarterly or annual reports.
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
The profits of Abbott Laboratories are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
You can learn more about the earnings of Abbott Laboratories by reviewing the quarterly or annual reports or following the company presentations.
Over the past 12 months, Abbott Laboratories paid a dividend of 2.04 USD . This corresponds to a dividend yield of about 1.9 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.
The current dividend yield of Abbott Laboratories is 1.9 %.
Abbott Laboratories pays a quarterly dividend. This is distributed in the months of August, November, March, May.
Abbott Laboratories paid dividends every year for the past 25 years.
For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.09 %.
Abbott Laboratories is assigned to the 'Health' sector.
To receive the latest dividend of Abbott Laboratories from 5/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.
The last dividend was paid out on 5/15/2024.
In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.
The dividends of Abbott Laboratories are distributed in USD.
The Abbott Laboratories stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.